Evidence map›Paper›PMID 33884473›Full record

ArticleEuropean radiology2021

Evaluation of amide proton transfer-weighted imaging for endometrial carcinoma histological features: a comparative study with diffusion kurtosis imaging.

Nan Meng, Xuejia Wang, Jing Sun, Zhun Huang, Zhen Yang, Jie Shang, Yan Bai, Wei Wei, Dongming Han, Hui Han and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Nan MengDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Xuejia WangDepartment of MR, The First Affiliated Hospital, Xinxiang Medical University, Weihui, China.
Jing SunDepartment of Pediatrics, Zhengzhou Central Hospital, Zhengzhou University, Zhengzhou, China.
Zhun HuangDepartment of Medical Imaging, Henan University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Zhen YangDepartment of Pediatrics, Zhengzhou Central Hospital, Zhengzhou University, Zhengzhou, China.
Jie ShangDepartment of Pathology, The First Affiliated Hospital, Xinxiang Medical University, Weihui, China.
Yan BaiDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Wei WeiDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Dongming HanDepartment of MR, The First Affiliated Hospital, Xinxiang Medical University, Weihui, China.
Hui HanBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Kaiyu WangMR Research China, GE Healthcare, Beijing, China.
Fengmin ShaoDepartment of Nephrology, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, Henan, China. fengminshao@126.com.
Meiyun WangDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, Henan, China. mywang@ha.edu.cn.
First Affiliated Hospital of Xinxiang Medical University · CNZhengzhou University · CNHenan Academy of Sciences · CNZhengzhou Central Hospital · CNCedars-Sinai Medical Center · USHenan University · CN

Funding

the Henan Medical Science and Technology Research Program 2018020357,2018020367the National Key R&D Program of China 2017YFE0103600the National Natural Science Foundation of China 81720108021, 31470047Zhengzhou Collaborative Innovation Major Project 20XTZX05015Zhongyuan Thousand Talents Plan Project - Basic Research Leader Talent ZYQR201810117
6 · The paper itself

Abstract

objectivesTo investigate whether amide proton transfer-weighted imaging (APTWI) and diffusion kurtosis imaging (DKI) can be used to evaluate endometrial carcinoma (EC) in terms of clinical type, histological grade, subtype, and Ki-67 index.

methodsEighty-eight patients with EC underwent pelvic DKI and APTWI. The non-Gaussian diffusion coefficient (D

resultsThe MTRasym (3.5 ppm) and K

conclusionBoth DKI- and APTWI-related parameters have potential as imaging markers in estimating the histological features of EC, while DKI shows better performance than APTWI in this study. KEY POINTS: • DKI and APTWI can be used to preliminarily evaluate the histological characteristics of endometrial carcinoma (EC). • The K

Indexed as

Endometrial NeoplasmsProtonsAmidesDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingFemaleHumansReproducibility of ResultsAmidesProtonsDiffusion magnetic resonance imagingEndometrial neoplasmsMagnetization transfer contrast imaging

Identifiers

PMID33884473
OpenAlexW3152920610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.